Recent progress in Lyme disease and remaining challenges
Lyme disease (also known as Lyme borreliosis) is the most common vector-borne disease in
the United States with an estimated 476,000 cases per year. While historically, the long-term …
the United States with an estimated 476,000 cases per year. While historically, the long-term …
Lyme disease in humans
JD Radolf, K Strle, JE Lemieux, F Strle - Current issues in molecular …, 2021 - mdpi.com
Lyme disease (Lyme borreliosis) is a tick-borne, zoonosis of adults and children caused by
genospecies of the Borrelia burgdorferi sensu lato complex. The ailment, widespread …
genospecies of the Borrelia burgdorferi sensu lato complex. The ailment, widespread …
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
Lyme disease is the most common vector-borne infectious disease in the United States, in
part because a vaccine against it is not currently available for humans. We propose utilizing …
part because a vaccine against it is not currently available for humans. We propose utilizing …
Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence
A Jafarzadeh, M Nemati, S Jafarzadeh, P Nozari… - Journal of …, 2022 - Springer
Purpose The safety and efficacy of the several types of COVID-19 vaccines, including mRNA-
based, viral vector-based, and inactivated vaccines, have been approved by WHO. The …
based, viral vector-based, and inactivated vaccines, have been approved by WHO. The …
Molecular mimicry as a mechanism of autoimmune disease
MF Cusick, JE Libbey, RS Fujinami - Clinical reviews in allergy & …, 2012 - Springer
A variety of mechanisms have been suggested as the means by which infections can initiate
and/or exacerbate autoimmune diseases. One mechanism is molecular mimicry, where a …
and/or exacerbate autoimmune diseases. One mechanism is molecular mimicry, where a …
The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious …
GP Wormser, RJ Dattwyler, ED Shapiro… - Clinical Infectious …, 2006 - academic.oup.com
Evidence-based guidelines for the management of patients with Lyme disease, human
granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and …
granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and …
Lyme borreliosis
G Stanek, GP Wormser, J Gray, F Strle - The Lancet, 2012 - thelancet.com
Lyme borreliosis (Lyme disease) is caused by spirochaetes of the Borrelia burgdorferi sensu
lato species complex, which are transmitted by ticks. The most common clinical …
lato species complex, which are transmitted by ticks. The most common clinical …
The emergence of Lyme disease
AC Steere, J Coburn, L Glickstein - The Journal of clinical …, 2004 - Am Soc Clin Investig
Since its identification nearly 30 years ago, Lyme disease has continued to spread, and
there have been increasing numbers of cases in the northeastern and north central US. The …
there have been increasing numbers of cases in the northeastern and north central US. The …
Diagnosis of Lyme borreliosis
ME Aguero-Rosenfeld, G Wang… - Clinical microbiology …, 2005 - Am Soc Microbiol
SUMMARY A large amount of knowledge has been acquired since the original descriptions
of Lyme borreliosis (LB) and of its causative agent, Borrelia burgdorferi sensu stricto. The …
of Lyme borreliosis (LB) and of its causative agent, Borrelia burgdorferi sensu stricto. The …
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
T Sturniolo, E Bono, J Ding, L Raddrizzani… - Nature …, 1999 - nature.com
Most pockets in the human leukocyte antigen–group DR (HLA-DR) groove are shaped by
clusters of polymorphic residues and, thus, have distinct chemical and size characteristics in …
clusters of polymorphic residues and, thus, have distinct chemical and size characteristics in …